Chemokines and Viral Infections of the CNS

作者: Douglas M. , Robyn S.

DOI: 10.5772/24720

关键词:

摘要: A critical factor in the host immune response to invading pathogens, such as viral infections, is recruitment and infiltration of cells infected tissues. Although goal recruited leukocytes eliminate collateral tissue damage may be induced process, and, certain circumstances, pose a serious threat survival host. The central nervous system (CNS) unique site with limited regenerative potential therefore low threshold for inflammation-induced damage. However, CNS become target life-threatening it imperative that immunological surveillance efficient effector responses occur this organ aid pathogen clearance. traditionally characterized “immune privilege,” evidence suggests antiviral immunity does (Carson et al., 2006). Understanding how local inflammatory within regulated key understanding pathogenesis infections developing therapies promote protective limit pathogenic responses. Leukocyte any generally complex, multistep process. Under normal conditions, leukocyte migration into maintained at levels (Hickey, 2001). During virus-induced inflammation, however, extravasation increased targeted specific compartments depending on stimulus region. Chemokines chemokine receptors have been identified pivotal players regulating cell trafficking CNS. consist large family small, structurally related, chemotactic cytokines are involved lymphocytic traffic both lymphoid nonlymphoid organs emigration sites injury infection (Rossi & Zlotnik, 2000). select entry based their expression receptors, G-protein-coupled surface which characteristic seven transmembrane structure (Premack Schall, 1996). In addition targeting distinct populations during chemokines emerged crucial mediators variety biological processes including development homeostasis. With regard inflammation CNS, strategic position coordinate through regulation also final positioning activation infiltrating cells. Immune function dictate host-pathogen relationship

参考文章(112)
J. E. Allan, J. E. Dixon, P. C. Doherty, Nature of the inflammatory process in the central nervous system of mice infected with lymphocytic choriomeningitis virus. Current Topics in Microbiology and Immunology. ,vol. 134, pp. 131- 143 ,(1987) , 10.1007/978-3-642-71726-0_6
M.J. Buchmeier, R.M. Welsh, F.J. Dutko, M.B.A. Oldstone, The virology and immunobiology of lymphocytic choriomeningitis virus infection. Advances in Immunology. ,vol. 30, pp. 275- 331 ,(1980) , 10.1016/S0065-2776(08)60197-2
Peter L. Summers, Doria R. Dubois, Tatsuo Hase, Comparative study of mouse brains infected with Japanese encephalitis virus by intracerebral or intraperitoneal inoculation. International Journal of Experimental Pathology. ,vol. 71, pp. 857- 869 ,(1990)
Michael S. Diamond, Bimmi Shrestha, Erin Mehlhop, Elizabeth Sitati, Michael Engle, Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis Virus Viral Immunology. ,vol. 16, pp. 259- 278 ,(2003) , 10.1089/088282403322396082
Heribert Weigand, John Hotchin, Studies of lymphocytic choriomeningitis in mice. I. The relationship between age at inoculation and outcome of infection. Journal of Immunology. ,vol. 86, pp. 392- 400 ,(1961)
Cory M. Hogaboam, Steven L. Kunkel, Nicholas W. Lukacs, Robert M. Strieter, Stephen W. Chensue, Monocyte chemoattractant protein-1 synthesis by murine lung fibroblasts modulates CD4+ T cell activation. Journal of Immunology. ,vol. 160, pp. 4606- 4614 ,(1998)
O Marker, A R Thomsen, J P Christensen, E C Andersson, A Scheynius, Alpha 4 integrin directs virus-activated CD8+ T cells to sites of infection. Journal of Immunology. ,vol. 154, pp. 5293- 5301 ,(1995)
Vito G. Sasseville, Charles R. Mackay, Andrew A. Lackner, Douglas R. Pauley, Keith G. Mansfield, Martha M. Smith, Douglas J. Ringler, Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. American Journal of Pathology. ,vol. 149, pp. 1459- 1467 ,(1996)
Michael J Buchmeier, Thomas E Lane, Viral-induced neurodegenerative disease. Current Opinion in Microbiology. ,vol. 2, pp. 398- 402 ,(1999) , 10.1016/S1369-5274(99)80070-8